- Home
- MOVE vs NCNA Comparison
MOVE vs NCNA Comparison
Compare MOVE & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- NCNA
- Stock Information
- Founded
- MOVE 2018
- NCNA 1997
- Country
- MOVE United States
- NCNA United Kingdom
- Employees
- MOVE N/A
- NCNA N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- NCNA Health Care
- Exchange
- MOVE Nasdaq
- NCNA Nasdaq
- Market Cap
- MOVE 4.7M
- NCNA 4.5M
- IPO Year
- MOVE 2021
- NCNA 2017
- Fundamental
- Price
- MOVE $0.77
- NCNA $0.06
- Analyst Decision
- MOVE Buy
- NCNA Buy
- Analyst Count
- MOVE 1
- NCNA 2
- Target Price
- MOVE $30.00
- NCNA $25.00
- AVG Volume (30 Days)
- MOVE 1.3M
- NCNA 268.7M
- Earning Date
- MOVE 08-13-2025
- NCNA 08-14-2025
- Dividend Yield
- MOVE N/A
- NCNA N/A
- EPS Growth
- MOVE N/A
- NCNA N/A
- EPS
- MOVE N/A
- NCNA N/A
- Revenue
- MOVE $1,013,000.00
- NCNA N/A
- Revenue This Year
- MOVE $1,460.71
- NCNA N/A
- Revenue Next Year
- MOVE $96.77
- NCNA N/A
- P/E Ratio
- MOVE N/A
- NCNA N/A
- Revenue Growth
- MOVE N/A
- NCNA N/A
- 52 Week Low
- MOVE $0.51
- NCNA $0.03
- 52 Week High
- MOVE $6.97
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- MOVE 55.19
- NCNA 43.92
- Support Level
- MOVE $0.68
- NCNA $0.04
- Resistance Level
- MOVE $0.78
- NCNA $0.07
- Average True Range (ATR)
- MOVE 0.09
- NCNA 0.01
- MACD
- MOVE 0.02
- NCNA 0.01
- Stochastic Oscillator
- MOVE 89.47
- NCNA 18.57
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.